• About Us
    • Who Are We
    • Our Infrastructure and Technology
    • Our Team
    • Our Services
  • Media Hub
    • News & Press Release
    • Knowledge Hub
    • Download Resources
    • White Papers
    • Case Studies
    • Events & Upcoming Events
Header Logo
  • End to End Sequencing Solutions
  • Precision Diagnostics
  • Population Omics Program
  • Research & Discovery
  • Strategic Partnerships
Contact Us
  • End to End Sequencing Solutions
  • Precision Diagnostics
  • Population Omics Program
  • Research & Discovery
  • Strategic Partnerships
  • About Us
    About Us
    • Who Are We
    • Our Infrastructure and Technology
    • Our Team
      Our Team
      • Dr. David Kavanagh
      • Dr. Ahmad Al Awadhi
      • Dr. Val Zvereff Medical Director
      • Dr. Tiago Magalhaes
      • Dr. Azza Attia
      • Dr. Javier Quilez
      • Hanil Sajad
      • Yasser Jahangir
    • Our Services
      Our Services
      • End to End Sequencing Solutions
      • Precision Diagnostics
      • Population Omics Program
  • Media Hub
    Media Hub
    • News & Press Release
    • Knowledge Hub
    • Download Resources
    • White Papers
    • Case Studies
    • Events & Upcoming Events
Contact Us
  • Home
  • News & Press Release

News & Press Release

Biogenix revolutionizes the interpretation of molecular data, transforming it into practical insights that propel advancements in precision, predictive, and personalized healthcare.

News
04 Jun 2026
Actionable genetic insights for better health and patient care, Enabling earlier interventions through real-time genomic intelligence.
Mubadala Investment Company (Mubadala) and Siemens Energy, one of the world’s leading energy technology companies, have signed a Memorandum of Understanding (MoU) with the intention of creating a strategic partnership to drive investment and development of advanced technology, manufacture of equipment, and green hydrogen and synthetic fuel production. The initial focus of activity will be in Abu Dhabi and it is intended this will be expanded to international markets over time.
News
25 Jun 2026
Abu Dhabi Advances Gene Editing Therapies Targeting Rare Diseases Through Strategic Global Collaboration
News
18 Aug 2025
Abu Dhabi launches newborn genetic screening to detect over 800 childhood conditions
News
03 Jun 2025
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
News
25 Apr 2025
Abu Dhabi advances precision medicine for Alzheimer’s disease patients through pharmacogenomics reports
News
25 Dec 2024
UAE to introduce mandatory premarital genetic testing for Emiratis from January
News
08 Nov 2024
Department of Health – Abu Dhabi, M42 and Khalifa University highlight emirate’s genomics and precision medicine advancements at American Society of Human Genetics Annual Meeting
News
06 May 2024
M42 signs groundbreaking agreement with AstraZeneca to advance prevention and precision medicine for breast cancer
We turn data
into direction
About Us
  • Who Are We
  • Our Infrastructure and Technology
  • Our Team
  • Our Services
Our Services
  • End to End Sequencing Solutions
  • Precision Diagnostics
  • Population Omics Program
Media & Resources
  • News & Press Release
  • Knowledge Hub
  • Download Resources
  • White Papers
  • Case Studies
  • Events & Upcoming Events
Strategic Partnerships
Research & Discovery
Contact Us
© 2026 Biogenix, All Rights Reserved.